Search
- Report
Letter to the Honorable Bruce L. Braley
- Blog Post
CBO has been asked for additional information about the projected effects of the Patient Protection and Affordable Care Act (PPACA), the pending health care reform legislation, on the federal budget and on the balance in the Hospital Insurance (HI) trust fund, from which Medicare Part A benefits are paid.
- Report
Letter to the Honorable Harry Reid
- Blog Post
CBO has discovered an error in the cost estimate released yesterday related to the longer-term budgetary effects of the managers amendment to the Patient Protection and Affordable Care Act. Correcting that error has no impact on the estimated effects of the legislation during the 20102019 period. However, the correction reduces the degree to which the legislation would lower federal deficits in the decade after 2019.
- Cost Estimate
Cost estimate for the amendment in the nature of a substitute to H.R. 3590, incorporating the effects of changes proposed in the manager's amendment released on December 19, 2009
- Report
Letter to the Honorable John D. Rockefeller IV
- Blog Post
Pharmaceutical companies' efforts to promote prescription drugs have attracted the attention of policymakers because such activities may affect the rate at which different drugs are prescribed and consumed, the total amount spent on health care, and, ultimately, health outcomes. Yesterday CBO released a brief highlighting trends in promotional spending for prescription drugs and market characteristics that influence promotional strategies.
- Report
Economic and Budget Issue Brief
- Report
Letter to the Honorable Evan Bayh
- Blog Post
This morning CBO released an analysis of how health insurance premiums might be affected by enactment of the Patient Protection and Affordable Care Act, as proposed by Senator Reid on November 18, 2009. The marketplace for health insurance is complex and many-faceted, and the impact of a proposal on premiums cannot be readily summarized in one or two numbers.